Aptus Capital Advisors, LLC First Trust Nyse Arca Biotechn Transaction History

Aptus Capital Advisors, LLC

  • $8.9 Billion
  • Q4 2024

A detailed history of Aptus Capital Advisors, LLC transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 347 shares of FBT stock, worth $60,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
347
Previous 2 17250.0%
Holding current value
$60,506
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$161.65 - $178.69 $55,769 - $61,648
345 Added 17250.0%
347 $57,000
Q3 2023

Nov 08, 2023
SELL
$145.69 - $157.89 $5,244 - $5,684
-36 Reduced 94.74%
2 $0
Q4 2022

Feb 13, 2023
SELL
$132.87 - $159.04 $265 - $318
-2 Reduced 5.0%
38 $5,000
Q2 2022

Jul 29, 2022
SELL
$123.32 - $155.54 $123 - $155
-1 Reduced 2.44%
40 $5,000
Q1 2022

May 04, 2022
BUY
$137.27 - $163.07 $5,353 - $6,359
39 Added 1950.0%
41 $6,000
Q1 2021

May 06, 2021
BUY
$156.06 - $184.84 $312 - $369
2 New
2 $0

Others Institutions Holding FBT

# of Institutions
276
Shares Held
3.69M
Call Options Held
5.3K
Put Options Held
0
View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

FBT Quotes by TradingView
  • Ticker FBT
  • Sector ETFs
  • Industry ETFs
More about FBT
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email